Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 5Smoking Cessation 1Postoperative Complications 1Motor Activity 1Lymphoma, Follicular 1Inflammation 1HIV Seropositivity 1HIV Infections 1Asthma 1

Interventions

Exercise 5Vitamin D 3Resistance Training 3Omeprazole 3Etanercept 3Dexmedetomidine 3Ascorbic Acid 3salicylsalicylic acid 2palbociclib 2epigallocatechin gallate 2XENP 1595 2Tea 2Tablets 2Surgical Procedures, Operative 2Sufentanil 2Spironolactone 2Probiotics 2Pioglitazone 2Oxycodone 2Nutrition Assessment 2Morphine 2Metformin 2Ketorolac 2Infliximab 2Ibuprofen 2Fish Oils 2Endurance Training 2Colchicine 2Blood Specimen Collection 2Aspirin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Inflammation × Spirometry × Clear all
NCT03654105 2026-03-27

SMILE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Active not recruiting
2,000 enrolled
Thoracic

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡